Neuren Pharmaceuticals | NEU - Aktuelle Verpflichtungen

Aktienkurs
12.55
Täglich Wechseln
0.52 4.28%
Monatlich
7.41%
Jährlich
35.04%
Q2 Prognose
11.77




Aktuelle Verpflichtungen Veränderung Datum
Akebia Therapeutics USD 162.94M 29.56M 2025-12
Alaunos Therapeutics USD 921K 153K 2025-09
Avita Medical AUD 62.68M 77K 2025-12
Clinuvel Pharmaceuticals AUD 17.85M 9.36M 2025-12
Dianthus Therapeutics USD 30.73M 6.88M 2025-12
Genetic Signatures AUD 4.78M 680K 2025-12
Ionis Pharmaceuticals USD 783M 120.46M 2025-12
Medical Developments International AUD 5.56M 2.26M 2025-12
Neuren Pharmaceuticals AUD 4.34M 3.58M 2025-12
Organon & Co USD 2.68B 117M 2025-09
Paradigm Biopharmaceuticals AUD 16.6M 13.37M 2025-12
PYC Therapeutics AUD 11.01M 1.31M 2025-12
Starpharma Holdings AUD 4.61M 614K 2025-12
Tectonic Therapeutic USD 9.67M 293K 2025-12
Telix Pharmaceuticals AUD 231.62M 66.96M 2025-12
Viatris USD 7.09B 269.8M 2025-12
Xeris Pharmaceuticals USD 109.57M 6.63M 2025-12